Ceo, Co-Founder
CurrentAt Weave, we focus on one of the most boring, but also one of the most critical, domains in the drug development process, regulatory reporting. Our AutoIND platform will radically accelerate the process of preparing and submitting Investigational New Drug (IND) applications to the FDA.We turn the complexity of biomedicine into simple, clear narratives, getting new therapies to patients who desperately need them, at the speed of AI.